Human Preadipocytes Display a Depot-Specific Susceptibility to Apoptosis

Adipose tissue mass is determined by both the number and volume of adipose cells. Adipose cell number reflects the balance of cell acquisition and cell loss, whereas adipose cell volume represents the balance of lipolysis and lipogenesis. It is well recognized that insulin resistance, NIDDM, and other metabolic disorders are associated more strongly with increased omental adiposity than with subcutaneous adiposity. Depotrelated differences exist in adipocyte responses to lipolytic and lipogenic stimuli, in adipocyte apoptosis, and in the potential for preadipocyte replication and differentiation. In the present study, we address the question of whether there might also be a site-specific difference in the susceptibility of human preadipocytes to apoptosis. Paired samples of human omental and subcutaneous preadipocytes from 12 individuals were cultured, and apoptosis was induced by serum deprivation or treatment with tumor necrosis factor (TNF)-α for 4 h. Cells were then stained with acridine orange, and apoptotic indices were calculated as the fraction of cells showing nuclear condensation. Under both conditions, in 9 of 11 subjects, apoptotic indices were substantially greater in preadipocytes from the omental depot than in those from the subcutaneous depot, and mean apoptotic indices were more than twofold higher in omental cells (serum-free medium: P < 0.05; TNF-α: P < 0.02; paired t test). Omental preadipocytes are therefore more susceptible to two different apoptotic stimuli than subcutaneous preadipocytes, demonstrating another intrinsic site-specific difference between human adipose cells of the two depots. These results suggest that the regulation of adipose tissue distribution in humans could involve depot-specific differences in rates of preadipocyte apoptosis.

[1]  S. O’Rahilly,et al.  Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. , 1997, Diabetes.

[2]  P. Björntorp,et al.  Regional differences and effect of weight reduction on human fat cell metabolism , 1979, European journal of clinical investigation.

[3]  K. Umesono,et al.  Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. , 1998, The Journal of clinical investigation.

[4]  P. Björntorp Adipose tissue distribution and function. , 1991, International journal of obesity.

[5]  F. Lönnqvist,et al.  Mechanisms underlying regional differences in lipolysis in human adipose tissue. , 1989, The Journal of clinical investigation.

[6]  M. Berlan,et al.  Alpha‐adrenergic antilipolytic effect of adrenaline in human fat cells of the thigh: comparison with adrenaline responsiveness of different fat deposits , 1979, European journal of clinical investigation.

[7]  A. Kissebah,et al.  Regional adiposity and morbidity. , 1994, Physiological reviews.

[8]  K. Heidenreich,et al.  Apoptosis Induced by Withdrawal of Trophic Factors Is Mediated by p38 Mitogen-activated Protein Kinase* , 1997, The Journal of Biological Chemistry.

[9]  H. Hauner,et al.  Tumor necrosis factor-alpha prevents the differentiation of human adipocyte precursor cells and causes delipidation of newly developed fat cells. , 1993, The Journal of clinical endocrinology and metabolism.

[10]  C. Bouchard,et al.  Genetic and nongenetic determinants of regional fat distribution. , 1993, Endocrine reviews.

[11]  P. Björntorp,et al.  Adipocyte precursor cells in obese and nonobese humans. , 1985, Metabolism: clinical and experimental.

[12]  J. Prins,et al.  Apoptosis of human adipocytes in vitro. , 1994, Biochemical and biophysical research communications.

[13]  S. O’Rahilly,et al.  Regulation of adipose cell number in man. , 1997, Clinical science.

[14]  G. Evan,et al.  A License to Kill , 1996, Cell.

[15]  S. O’Rahilly,et al.  Depot- and Sex-Specific Differences in Human Leptin mRNA Expression: Implications for the Control of Regional Fat Distribution , 1997, Diabetes.

[16]  H. Kather,et al.  Human fat cell adenylate cyclase: regional differences in adrenaline responsiveness , 1977, European journal of clinical investigation.

[17]  J. Prins,et al.  Human adipocyte apoptosis occurs in malignancy. , 1994, Biochemical and biophysical research communications.

[18]  J. Hughes,et al.  Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. , 1994, The Journal of clinical investigation.

[19]  M. Compton,et al.  Brain administration of leptin causes deletion of adipocytes by apoptosis. , 1998, Endocrinology.

[20]  P. Arner,et al.  Differences at the Receptor and Postreceptor Levels Between Human Omental and Subcutaneous Adipose Tissue in the Action of Insulin on Lipolysis , 1983, Diabetes.

[21]  A. Raasmaja,et al.  Alpha 2A-adrenergic regulation of cyclic AMP accumulation and lipolysis in human omental and subcutaneous adipocytes. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[22]  M. Jensen,et al.  Effects of body fat distribution on regional lipolysis in obesity. , 1991, The Journal of clinical investigation.

[23]  S. O’Rahilly,et al.  Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. , 1997, The Journal of clinical investigation.

[24]  B. Spiegelman,et al.  Adipogenesis and Obesity: Rounding Out the Big Picture , 1996, Cell.